Advanced search
Publication Cover
Acta Oncologica Volume 56, 2017 - Issue 4
Journal homepage
1,853
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: BREAST CANCER

Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen

Johan RosellRegional Cancer Center South East Sweden, Linköping, Sweden; ;Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden; Correspondence[email protected]
,
Bo NordenskjöldOncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden;
,
Nils-Olof BengtssonDepartment of Oncology, Umeå University Hospital, Umeå, Sweden;
,
Tommy FornanderDepartment of Oncology, Karolinska University Hospital, Stockholm, Sweden;
,
Thomas HatschekDepartment of Oncology, Karolinska University Hospital, Stockholm, Sweden;
,
Henrik LindmanDepartment of Oncology, Uppsala University Hospital, Uppsala, Sweden;
,
Per-Olof MalmströmSkånes Department of Oncology, Skåne University Hospital, Lund, Sweden;
,
Arne WallgrenDepartment of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden;
,
Olle StålOncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden;
&
John CarstensenDepartment of Medical and Health Sciences, Linköping University, Linköping, Sweden
 show all
Pages 614-617 | Received 22 Nov 2016, Accepted 09 Dec 2016, Published online: 12 Jan 2017

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Annet Bens, Rikke Langballe, Jonine L. Bernstein, Deirdre Cronin-Fenton, Søren Friis & Lene Mellemkjaer. (2019) Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies. Acta Oncologica 58:11, pages 1581-1593.
Read now
Maria A Velez, Timothy F Burns & Laura P Stabile. (2019) The estrogen pathway as a modulator of response to immunotherapy. Immunotherapy 11:13, pages 1161-1176.
Read now

Articles from other publishers (18)

Jennifer S. Ferris, Devon A. Morgan, Ashley S. Tseng, Mary Beth Terry, Ruth Ottman, Chin Hur, Jason D. Wright & Jeanine M. Genkinger. (2023) Risk factors for developing both primary breast and primary ovarian cancer: A systematic review. Critical Reviews in Oncology/Hematology 190, pages 104081.
Crossref
Anna Nordenskjöld, Helena Fohlin, Johan Rosell, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per Malmström, Lisa Rydén, Arne Wallgren, Olle Stål & Bo Nordenskjöld. (2023) Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy. The Breast 71, pages 63-68.
Crossref
Emaan Haque, Ali H Mushtaq, Radwan Alkhatib, Hamed Alhusaini & Kausar Suleman. (2023) An Unexpected Diagnosis of Second Primary Malignancy in a Breast Cancer Survivor: A Case Report. Cureus.
Crossref
Chihiro Inoue, Yasuhiro Miki & Takashi Suzuki. (2023) New Perspectives on Sex Steroid Hormones Signaling in Cancer-Associated Fibroblasts of Non-Small Cell Lung Cancer. Cancers 15:14, pages 3620.
Crossref
Kevin Yu Wang, Chung-Shien Lee, Prashant Vempati, Rajiv Sharma, Nina Kohn & Nagashree Seetharamu. (2023) Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study. Clinical Lung Cancer.
Crossref
Dooreh Kim, Jooyoung Oh, Jeong-Ho Seok, Hye Sun Lee, Soyoung Jeon & Chang Ik Yoon. (2023) Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea. Diagnostics 13:4, pages 792.
Crossref
Miao Li, Yu Cai, Xi Chen, Luyong Zhang, Zhenzhou Jiang & Qinwei Yu. (2022) Tamoxifen induced hepatic steatosis in high-fat feeding rats through SIRT1-Foxo1 suppression and LXR-SREBP1c activation. Toxicology Research 11:4, pages 673-682.
Crossref
Jill M Siegfried. (2022) Sex and Gender Differences in Lung Cancer and Chronic Obstructive Lung Disease. Endocrinology 163:2.
Crossref
Tamar B Nobel, Rebecca A Carr, Raul Caso, Jennifer Livschitz, Samuel Nussenzweig, Meier Hsu, Kay See Tan, Smita Sihag, Prasad S Adusumilli, Matthew J Bott, Robert J Downey, James Huang, James M Isbell, Bernard J Park, Gaetano Rocco, Valerie W Rusch, David R Jones & Daniela Molena. (2021) Primary lung cancer in women after previous breast cancer. BJS Open 5:6.
Crossref
Anna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, Mikael Johansson, Irma Fredriksson, Carl Blomqvist, Lars Holmberg, Greger Nilsson & Malin Sund. (2021) Risk of primary lung cancer after adjuvant radiotherapy in breast cancer—a large population-based study. npj Breast Cancer 7:1.
Crossref
Patricia A. Young, Diana C. Márquez-Garbán, Zorawar Singh Noor, Neda Moatamed, David Elashoff, Tristan Grogan, Tahmineh Romero, Hironobu Sasano, Ryoko Saito, Rebecca Rausch, Nalo Hamilton, Steven M. Dubinett, Edward B. Garon & Richard J. Pietras. (2021) Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC. JTO Clinical and Research Reports 2:4, pages 100150.
Crossref
Kevin Y Wang, James Newman, Chung-Shien Lee & Nagashree Seetharamu. (2021) Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer. SAGE Open Medicine 9, pages 205031212110177.
Crossref
Krzysztof Jabłoński, Łukasz Kurek, Maciej Żukowski, Natalia Data-Jabłońska, Karolina Żukowska, Anna J. Milewska, Aleksandra Lipka & Marcin Jóźwik. (2020) Elastography of Endometrium in Women Taking Tamoxifen: A New Approach to an Old Diagnostic Problem. Journal of Clinical Medicine 9:12, pages 3870.
Crossref
Günter Emons, Alexander Mustea & Clemens Tempfer. (2020) Tamoxifen and Endometrial Cancer: A Janus-Headed Drug. Cancers 12:9, pages 2535.
Crossref
Tanner Smida, Tullia C. Bruno & Laura P. Stabile. (2020) Influence of Estrogen on the NSCLC Microenvironment: A Comprehensive Picture and Clinical Implications. Frontiers in Oncology 10.
Crossref
Rong Wang, Zhiqiang Yin, Lingxiang Liu, Wen Gao, Wei Li, Yongqian Shu & Jiali Xu. (2018) Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women. Frontiers in Oncology 8.
Crossref
Audrey Fleury, Olivier Pirrello, Christine Maugard, Carole Mathelin & Christelle Linck. (2018) Breast cancer and ovarian tissue cryopreservation: Review of the literature. Journal of Gynecology Obstetrics and Human Reproduction 47:8, pages 351-357.
Crossref
Hong-Tai Chang, Hsiang-Ju Pan & Chien-Hung Lee. (2018) Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients. Clinical Breast Cancer 18:4, pages e677-e685.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.